The role of hypercoagulability in ischemic colitis

References

• PDHiggins, KJDavis, LLaine. Systematic review: the epidemiology of ischaemic colitis. Aliment Pharmacol Ther 2004;19:729–38.
   PubMed Web of Science ®Google Scholar
• ATheodoropoulou, IEKoutroubakis. IC: clinical practice in diagnosis and treatment. World J Gastroenterol 2008;14:7302–8.
   PubMed Web of Science ®Google Scholar
• MLa, ATailor, MD’ Amico, RJFlower, MPerretti. Analysis of the protection afforded by annexin 1 in ischemia-reperfusion injury: focus on neutrophil recruitment. Eur J Pharmacol 2001;429:263–78.
   PubMed Web of Science ®Google Scholar
• JCFernández, LNCalvo, EGVázquez, MJGarcía García, MTAlves Pérez, IMSilva, et al. Risk factors associated with the development of ischemic colitis. World J Gastroenterol 2010;16:4564–9.
   PubMed Web of Science ®Google Scholar
• AMWalker, RLBohn, CCali, SFCook, ANAjene, BESands. Risk factors for colon ischemia. Am J Gastroenterol 2004;99:1333–7.
   PubMed Web of Science ®Google Scholar
• BTGreen, DATendler. Ischemic colitis: a clinical review. South Med J 2005;98:217–22.
   PubMed Web of Science ®Google Scholar
• JSreenarasimhaiah. Diagnosis and management of intestinal ischaemic disorders. BMJ 2003;326:1372–6.
   PubMed Web of Science ®Google Scholar
• RDNieto, MVarcada, OAOgunbiyi, MCWinslet. Systematic review on the treatment of ischemic colitis. Colorectal Dis 2011;13:744–7.
   PubMed Web of Science ®Google Scholar
• IEKoutroubakis, ASfiridaki, ATheodoropoulou, EAKouroumalis. Role of acquired and hereditary thrombotic risk factors in colon ischemia of ambulatory patients. Gastroenterology 2001;121:561–5.
   PubMed Web of Science ®Google Scholar
• RMidian-Singh, APolen, CDurishin, RDCrock, FCWhittier, NFahmy. Ischemic colitis revisited: a prospective study identifying hypercoagulability as a risk factor. South Med J 2004;97:120–3.
   PubMed Web of Science ®Google Scholar
• ATheodoropoulou, ASfiridaki, POustamanolakis, EVardas, ALivadiotaki, ABoumpaki, et al. Genetic risk factors in young patients with Ischemic Colitis. Clin Gastroenterol Hepatol 2008;6:907–11.
   PubMed Web of Science ®Google Scholar
• JDanesh, SLewington, SGThompson, GDLowe, RCollins, JBKostis, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. J Am Med Assoc 2005;294:1799–809.
   PubMed Web of Science ®Google Scholar
• SKaptoge, IRWhite, SGThompson, AMWood, SLewington, GDLowe, et al. for the Fibrinogen Studies Collaboration. Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 2007;166:867–79.
   PubMed Web of Science ®Google Scholar
• Pde Moerloose, FBoehlen, MNeerman-Arbez. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost 2010;36:7–17.
   PubMed Web of Science ®Google Scholar
• JJStec, HSilbershatz, GHTofler, THMatheney, PSutherland, ILipinska, et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000;102:1634–8.
   PubMed Web of Science ®Google Scholar
• DALane, TBayston, RJOlds, ACFitches, DNCooper, DSMillar, et al. Antithrombin mutation database: 2nd (1997) update. For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thromb Haemost 1997;77:197–211.
   PubMed Web of Science ®Google Scholar
• PHReitsma. Protein C deficiency: summary of the 1995 database update. Nucleic Acids Res 1996;24:157–9.
   PubMed Web of Science ®Google Scholar
• SGandrille, DBorgel, HIreland, DALane, RSimmonds, PHReitsma, et al. Protein S deficiency: a database of mutations. For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thromb Haemost 1997;77:1201–14.
   PubMed Web of Science ®Google Scholar
• RMBertina, BPKoeleman, TKoster, FRRosendaal, RJDirven, Hde Ronde, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64–7.
   PubMed Web of Science ®Google Scholar
• SRPoort, FRRosendaal, PHReitsma, RMBertina. A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698–703.
   PubMed Web of Science ®Google Scholar
• IPabinger, BSchneider. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur thrombose- und hamostasefroschung (GTH) Study Group on natural inhibitors. Arterioscler Thromb Vasc Biol 1996;16:742–8.
   PubMed Web of Science ®Google Scholar
• JACaprini, SGoldshteyn, CJGlase, KHathaway. Thrombophilia testing in patients with venous thrombosis. Eur J Vasc Endovasc Surg 2005;30:550–5.
   PubMed Web of Science ®Google Scholar
• BDahlback, MCarlsson, PJSvensson. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004–8.
   PubMed Web of Science ®Google Scholar
• PFrosst, HJBlom, RMilos, PGoyette, CASheppard, RGMatthews, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111–13.
   PubMed Web of Science ®Google Scholar
• SKang, YWu, LLiu, XZhao, DZhang. Association of the A1298C polymorphism in MTHFR gene with ischemic stroke. J Clin Neurosci 2014;21:198–202.
   PubMed Web of Science ®Google Scholar
• ZYe, EHCLiu, JPTHiggins, BDKeanvey, GDOLowe, RCollins, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66155 cases and 91307 controls. Lancet 2006;367:651–8.
   PubMed Web of Science ®Google Scholar
• AETsantes, GKNikolopoulos, PGBagos, CTsiara, VKapsimali, ATravlou, et al. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysis. Blood Coagul Fibrinolysis 2007;18:497–504.
   PubMed Web of Science ®Google Scholar
• AETsantes, GKNikolopoulos, PGBagos, ERapti, GMantzios, VKapsimali, et al. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis: a meta-analysis. Thromb Haemost 2007;97:907–13.
   PubMed Web of Science ®Google Scholar
• AETsantes, GKNikolopoulos, PGBagos, SBonovas, PKopterides, GVaiopoulos. The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk. Thromb Res 2008;122:736–42.
   PubMed Web of Science ®Google Scholar
• CWFrancis. Plasminogen activator inhibitor-1 levels and polymorphisms. Arch Pathol Lab Med 2002;126:1401–4.
   PubMed Web of Science ®Google Scholar